-
the invention also relates to novel uses and methods of treatments using the aforementioned salts and/or compositions, in particular, with respect to the treatment of disturbances connected with either nitric oxide (NO) formation or impaired NO-system functions, in particular, hypertension, angina, impotence, circulatory and septic shock, stroke, inflammation, respiratory distress syndrome, adhesion and aggregation of platelets and leukocytes, endothelial dysfunction, gastrointestinal lesions, peristalsis disturbances, diabetes, pancreatitis, hypotension and Parkinson's disease
Another obstacle to clinical translation involves optimization of delivery methods for the therapeutics
1. What is glutathione, and why is it important
Rotate injection sites to minimize tissue irritation
CagriSema will not reach pharmacies until at least early 2027